SLC22A5 and neoplasm: Thus, OCTN2 represents a pharmacologically complex target with opposing functions depending on context: inhibiting OCTN2 might suppress carnitine-dependent metabolic transformation and proliferation in tumors where it functions as a growth promoter, while enhancing or selectively activating OCTN2 might facilitate chemotherapy uptake and efficacy in other tumor contexts.